Abstract The Semax 5mg peptide pen offers a precision-calibrated quantity of the synthetic ACTH(4-10) analogue, specifically designed for pilot studies, dose-titration protocols, and acute-phase cognitive research. As a potent regulatory peptide, Semax modulates the central nervous system by mimicking the N-terminal fragment of Adrenocorticotropic Hormone, stabilised by a C-terminal Pro-Gly-Pro sequence. This 5mg concentration is optimised for establishing the Minimum Effective Dose (MED) for neurotrophin upregulation (BDNF/NGF) and for investigating subtle modulation of executive function and attention in animal models, allowing researchers to isolate specific nootropic pathways without the potential saturation effects of higher-concentration variants.

Mechanism and Research Interest

Primary Biological Pathway: Neurotrophin Kinetics The 5mg formulation is the preferred reagent for investigating the kinetics of neurotrophin expression. While high doses trigger maximal release, the 5mg dose allows researchers to map the temporal onset of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) synthesis in the hippocampus. Research aims to determine the precise threshold required to activate the TrkB signalling pathway, distinguishing between the peptide’s immediate effects on synaptic transmission and its delayed effects on neuronal survival and differentiation.

Secondary Research Finding: Executive Function and Attention Semax is chemically related to the melanocortins, which influence attention and learning. The 5mg pen is extensively used in behavioural models of Attention Deficit Hyperactivity Disorder (ADHD). By modulating the turnover of dopamine and serotonin in the striatum and prefrontal cortex, low-dose Semax has been observed to improve selective attention and task completion rates. Researchers utilise this concentration to study these monoaminergic interactions, specifically looking for cognitive enhancement that occurs independently of psychomotor agitation.

Tertiary Research Finding: Ophthalmic Neuroprotection Due to its neurotrophic properties, Semax is also investigated for its protective effects on the optic nerve. In models of glaucomatous neuropathy or optic nerve ischaemia, the 5mg concentration is used to deliver localised neuroprotection. Studies suggest that even at lower systemic doses, Semax can preserve retinal ganglion cell density and maintain visual evoked potentials (VEP) following oxidative injury.

Long-term Genomic and Safety Observations A critical advantage of the 5mg dose is its suitability for defining the “therapeutic window.” Genomic toxicology studies utilise this concentration to verify that chronic administration does not desensitise the target receptors or disrupt the hypothalamic-pituitary-adrenal (HPA) axis. Unlike full-length ACTH, Semax 5mg does not elevate serum cortisol, a safety parameter that is rigorously validated via transcriptomic profiling of adrenal tissue in longitudinal studies.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). The synthesis ensures the absolute integrity of the Pro-Gly-Pro C-terminus, which is essential for the peptide’s metabolic stability and blood-brain barrier penetration.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen ratchet mechanism allows for the delivery of micro-quantities (e.g., 0.1mg increments). This precision is vital for conducting dose-response curves in small rodent models where body weight-adjusted dosing is critical.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The Semax 5mg Pen contains a peptide sequence that is stable but sensitive to thermal fluctuation. It must be refrigerated (2∘C to 8∘C). The shelf life is 12 months in the sealed state. Once opened, the bacteriostatic environment preserves the solution for 28 days. Given the lower total mass, researchers should plan to utilise the reagent efficiently within this window to ensure that the molar concentration administered remains constant.

Shipping Stability This product is shipped in medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to minimise any risk of enzymatic degradation or hydrolysis, we strongly recommend selecting the fastest available shipping option.

Freezing Warning Do not freeze. Freezing leads to ice crystal formation that can physically disrupt the peptide solution. This aggregation can impair the peptide’s ability to cross biological membranes, rendering it ineffective for CNS research. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The Semax 5mg Pen is the standard for Pilot Studies and Dose Optimisation. In neurocognitive research, “more” is not always “better.” High doses can sometimes obscure subtle improvements in memory or learning by inducing a ceiling effect. The 5mg pen allows researchers to start with a conservative dose and titrate upwards.

It provides a sterile, concentration-verified solution that eliminates the variability of manual weighing and mixing, ensuring that your baseline data is accurate and reproducible—a prerequisite for publishing high-impact neurobiology papers.

For researchers conducting comparative cognitive or anxiolytic studies, we recommend referencing:

• Semax 10mg:  (For maximal efficacy or ischaemic recovery models).

• Selank 5mg: (For comparative studies on anxiolytic modulation).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.